xCT KO in macrophages or anti‐PD‐L1 treatment effectively attenuated tumor growth, and the combination of xCT KO in macrophages and anti‐PD‐L1 achieved the most robust tumor suppression (Figure 6E). Here, SLC7A11 is linked to neoplasm.